Proteomic Markers and Early Prediction of Alzheimer’s Disease

被引:0
作者
Natalia V. Zakharova
Anna E. Bugrova
Maria I. Indeykina
Yana B. Fedorova
Igor V. Kolykhalov
Svetlana I. Gavrilova
Evgeny N. Nikolaev
Alexey S. Kononikhin
机构
[1] Emanuel Institute for Biochemical Physics,
[2] Russian Academy of Sciences,undefined
[3] Mental Health Research Center,undefined
[4] Skolkovo Institute of Science and Technology,undefined
来源
Biochemistry (Moscow) | 2022年 / 87卷
关键词
Alzheimer’s disease; protein makers; proteomics; early diagnosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:762 / 776
页数:14
相关论文
共 601 条
[1]  
Prince M.(2021)2021 Alzheimer’s disease facts and figures Alzheimer’s Dement. 17 327-406
[2]  
Bryce R.(2013)The global prevalence of dementia: A systematic review and metaanalysis Alzheimer’s Dement. 9 63-75
[3]  
Albanese E.(2013)Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers Lancet Neurol. 12 207-216
[4]  
Wimo A.(2013)Supporting evidence for using biomarkers in the diagnosis of MCI due to AD J. Neurol. 260 640-650
[5]  
Ribeiro W.(2009)Multimodal techniques for diagnosis and prognosis of Alzheimer’s disease Nature 461 916-922
[6]  
Jack C. R.(2019)Alzheimer’s disease: an update on pathobiology and treatment strategies Cell 179 312-339
[7]  
Knopman D. S.(2009)Classification and basic pathology of Alzheimer’s disease Acta Neuropathol. 118 5-36
[8]  
Jagust W. J.(2018)NIA-AA research framework: toward a biological definition of Alzheimer’s disease Alzheimer’s Dement. 14 535-562
[9]  
Petersen R. C.(1999)Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment Neurology 52 1397-1397
[10]  
Weiner M. W.(2012)MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults Neurology 78 84-90